Cargando…

Hydrothermotherapy in prevention and treatment of mild to moderate cases of COVID-19

COVID-19 is a new contagious disease caused by a new coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 is a disease that has reached every continent in the world; it has overloaded the medical system worldwide and it has been declared a pandemic by the World...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramirez, Francisco E., Sanchez, Albert, Pirskanen, Aki T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7668174/
https://www.ncbi.nlm.nih.gov/pubmed/33303302
http://dx.doi.org/10.1016/j.mehy.2020.110363
_version_ 1783610441452224512
author Ramirez, Francisco E.
Sanchez, Albert
Pirskanen, Aki T.
author_facet Ramirez, Francisco E.
Sanchez, Albert
Pirskanen, Aki T.
author_sort Ramirez, Francisco E.
collection PubMed
description COVID-19 is a new contagious disease caused by a new coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 is a disease that has reached every continent in the world; it has overloaded the medical system worldwide and it has been declared a pandemic by the World Health Organization. Currently there is no definite treatment for COVID-19. We realize that host immunity is a critical factor in the outcome of coronavirus 2 infection. Here, however, we review the pathophysiology of the disease with a focus on searching for what we can do to combat this new disease. From this, we find that coronavirus is sensitive to heat. We have thus focused on this area of vulnerability of the virus. The emphasis of this hypothesis is on the action of body heat—internal (fever) and external (heat treatment)—in activating the immune system and its antiviral activities, and specifically related to the coronavirus. We hypothesize from this review that heat treatments has the potential to prevent COVID-19 and to decrease the severity of mild and moderate cases of Coronavirus. We propose heat treatments for this uncontrolled worldwide coronavirus pandemic while studies are being done to test the effectiveness of heat treatments in the prevention and treatment of COVID-19.
format Online
Article
Text
id pubmed-7668174
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Authors. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-76681742020-11-16 Hydrothermotherapy in prevention and treatment of mild to moderate cases of COVID-19 Ramirez, Francisco E. Sanchez, Albert Pirskanen, Aki T. Med Hypotheses Article COVID-19 is a new contagious disease caused by a new coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 is a disease that has reached every continent in the world; it has overloaded the medical system worldwide and it has been declared a pandemic by the World Health Organization. Currently there is no definite treatment for COVID-19. We realize that host immunity is a critical factor in the outcome of coronavirus 2 infection. Here, however, we review the pathophysiology of the disease with a focus on searching for what we can do to combat this new disease. From this, we find that coronavirus is sensitive to heat. We have thus focused on this area of vulnerability of the virus. The emphasis of this hypothesis is on the action of body heat—internal (fever) and external (heat treatment)—in activating the immune system and its antiviral activities, and specifically related to the coronavirus. We hypothesize from this review that heat treatments has the potential to prevent COVID-19 and to decrease the severity of mild and moderate cases of Coronavirus. We propose heat treatments for this uncontrolled worldwide coronavirus pandemic while studies are being done to test the effectiveness of heat treatments in the prevention and treatment of COVID-19. The Authors. Published by Elsevier Ltd. 2021-01 2020-11-16 /pmc/articles/PMC7668174/ /pubmed/33303302 http://dx.doi.org/10.1016/j.mehy.2020.110363 Text en © 2020 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Ramirez, Francisco E.
Sanchez, Albert
Pirskanen, Aki T.
Hydrothermotherapy in prevention and treatment of mild to moderate cases of COVID-19
title Hydrothermotherapy in prevention and treatment of mild to moderate cases of COVID-19
title_full Hydrothermotherapy in prevention and treatment of mild to moderate cases of COVID-19
title_fullStr Hydrothermotherapy in prevention and treatment of mild to moderate cases of COVID-19
title_full_unstemmed Hydrothermotherapy in prevention and treatment of mild to moderate cases of COVID-19
title_short Hydrothermotherapy in prevention and treatment of mild to moderate cases of COVID-19
title_sort hydrothermotherapy in prevention and treatment of mild to moderate cases of covid-19
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7668174/
https://www.ncbi.nlm.nih.gov/pubmed/33303302
http://dx.doi.org/10.1016/j.mehy.2020.110363
work_keys_str_mv AT ramirezfranciscoe hydrothermotherapyinpreventionandtreatmentofmildtomoderatecasesofcovid19
AT sanchezalbert hydrothermotherapyinpreventionandtreatmentofmildtomoderatecasesofcovid19
AT pirskanenakit hydrothermotherapyinpreventionandtreatmentofmildtomoderatecasesofcovid19